Literature DB >> 30190431

Building immune tolerance through DNA vaccination.

Robin J Parks1,2,3, Emanuela Gussoni4,5.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30190431      PMCID： PMC6166841          DOI： 10.1073/pnas.1813461115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

1.  Dystrophin immunity in Duchenne's muscular dystrophy.

Authors:  Jerry R Mendell; Katherine Campbell; Louise Rodino-Klapac; Zarife Sahenk; Chris Shilling; Sarah Lewis; Dawn Bowles; Steven Gray; Chengwen Li; Gloria Galloway; Vinod Malik; Brian Coley; K Reed Clark; Juan Li; Xiao Xiao; Jade Samulski; Scott W McPhee; R Jude Samulski; Christopher M Walker
Journal:  N Engl J Med       Date:  2010-10-07       Impact factor: 91.245

2.  Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions.

Authors:  J Huard; R Roy; J P Bouchard; F Malouin; C L Richards; J P Tremblay
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

3.  Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy.

Authors:  Zejing Wang; James M Allen; Stanley R Riddell; Paul Gregorevic; Rainer Storb; Stephen J Tapscott; Jeffrey S Chamberlain; Christian S Kuhr
Journal:  Hum Gene Ther       Date:  2007-01       Impact factor: 5.695

4.  Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials.

Authors:  Virginia Arechavala-Gomeza; Maria Kinali; Lucy Feng; Michela Guglieri; Geraldine Edge; Marion Main; David Hunt; Jan Lehovsky; Volker Straub; Kate Bushby; Caroline A Sewry; Jennifer E Morgan; Francesco Muntoni
Journal:  Neuromuscul Disord       Date:  2010-04-14       Impact factor: 4.296

Review 5.  Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients.

Authors:  Daniel Skuk; Jacques P Tremblay
Journal:  Expert Opin Biol Ther       Date:  2015-06-16       Impact factor: 4.388

6.  Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.

Authors:  Scott Q Harper; Michael A Hauser; Christiana DelloRusso; Dongsheng Duan; Robert W Crawford; Stephanie F Phelps; Hollie A Harper; Ann S Robinson; John F Engelhardt; Susan V Brooks; Jeffrey S Chamberlain
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

7.  An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems.

Authors:  Peggy P Ho; Paulo Fontoura; Pedro J Ruiz; Lawrence Steinman; Hideki Garren
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

8.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.

Authors:  A P Monaco; R L Neve; C Colletti-Feener; C J Bertelson; D M Kurnit; L M Kunkel
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

9.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Authors:  J M Ervasti; K P Campbell
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

10.  Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophy.

Authors:  Peggy P Ho; Lauren J Lahey; Foteini Mourkioti; Peggy E Kraft; Antonio Filareto; Moritz Brandt; Klas E G Magnusson; Eric E Finn; Jeffrey S Chamberlain; William H Robinson; Helen M Blau; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 12.779
View more
  1 in total

Review 1.  Evolution of Cancer Vaccines-Challenges, Achievements, and Future Directions.

Authors:  Ban Qi Tay; Quentin Wright; Rahul Ladwa; Christopher Perry; Graham Leggatt; Fiona Simpson; James W Wells; Benedict J Panizza; Ian H Frazer; Jazmina L G Cruz
Journal:  Vaccines (Basel)       Date:  2021-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.